|
| U.S. Brand
Names |
|
| Calcibind® |

|
|
| Generic
Available |
|
|
No |

|
|
| Synonyms |
|
|
CSP; Sodium Cellulose Phosphate |

|
|
| Pharmacological Index |
|
|
Urinary Tract Product |

|
|
| Use |
|
|
Adjunct to dietary restriction to reduce renal calculi formation in
absorptive hypercalciuria type I |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Usual Dosage |
|
|
Adults: Oral: 5 g 3 times/day with meals; decrease dose to 5 g with main meal
and 2.5 g with each of two other meals when urinary calcium declines to <150
mg/day |

|
|
| Dietary
Considerations |
|
|
May be administered with meals |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Dosage Forms |
|
|
Powder: 2.5 g packets (90s), 300 g bulk
pack |

|
|
Copyright © 2007 Drugs Area
|